CONTERA PHARMA A/S — Credit Rating and Financial Key Figures

CONTERA PHARMA A/S (CVR number: 33062214) is a company from RUDERSDAL. The company recorded a gross profit of 20.6 mDKK in 2025. The operating profit was -5983.7 kDKK, while net earnings were -4783.8 kDKK. The profitability of the company measured by Return on Assets (ROA) was -6.8 %, which can be considered poor and Return on Equity (ROE) was -7.1 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 81.5 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. CONTERA PHARMA A/S's liquidity measured by quick ratio was 5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.